The Indian pharmaceutical industry has sought clarification from the Central Drugs Standard Control Organisation (CDSCO) on whether its new batch-wise digital clearance requirement for high-risk pharmaceutical solvents applies to export-oriented manufacturers. Medical…
India’s drug regulator has ordered manufacturers and suppliers of high-risk cough syrup ingredients to register every batch on a digital monitoring system and obtain a system-generated no-objection certificate before distribution. The order…
The Central Drugs Standard Control Organisation has confirmed that Natco Pharma's generic version of the SMA drug risdiplam was approved on 7 April 2025, days after bottles labelled 'Physician Sample/Clinical Trial' triggered…
Sanofi Healthcare has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for Qfitlia (fitusiran), a therapy to prevent bleeding in haemophilia patients. The approval covers adults and adolescents aged…
Shilpa Medicare’s Unit 4 in Jadcherla, Telangana, has received Good Manufacturing Practice (GMP) certification from AGES, Austria, following an inspection from July 27 to July 30, 2026. The company announced the certification…
The Central Drugs Standard Control Organisation has issued a fresh advisory cautioning against the indiscriminate use of painkillers and antibiotics, warning that repeated and prolonged use without medical supervision can lead to…
The central government is considering a retail-to-wholesale pharmacy licence ratio based on population, disease burden and existing licence density. The proposal was discussed at the 70th Drugs Consultative Committee meeting of the…
India's drug regulator has warned against two unauthorised Pakistani cosmetics, Goree beauty cream and Chandni whitening cream, found for sale on major e-commerce platforms including Amazon and Flipkart. The Central Drugs Standard…
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has issued an advisory cautioning against the indiscriminate, repeated or prolonged use of painkillers (NSAIDs) and antibiotics. The advisory highlights the risk…
The Central Drugs Standard Control Organisation (CDSCO) has identified one spurious and 220 not of standard quality (NSQ) drug samples from its August surveillance exercise, according to its NSQ and Spurious Drug…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.